Literature DB >> 21060314

Neuronal dysfunction in chronic spinal cord injury.

M Hubli1, M Bolliger, V Dietz.   

Abstract

This review describes the changes of spinal neuronal function that occur after a motor complete spinal cord injury (cSCI) in humans. In healthy subjects, polysynaptic spinal reflex (SR) evoked by non-noxious tibial nerve stimulation consists of an early SR component and rarely a late SR component. Soon after a cSCI, SR and locomotor activity are absent. After spinal shock; however, an early SR component re-appears associated with the recovery of locomotor activity in response to appropriate peripheral afferent input. Clinical signs of spasticity take place in the following months, largely as a result of non-neuronal changes. After around 1 year, the locomotor and SR activity undergo fundamental changes, that is, the electromyographic amplitude in the leg muscles during assisted locomotion exhaust rapidly, accompanied by a shift from early to dominant late SR components. The exhaustion of locomotor activity is also observed in non-ambulatory patients with an incomplete spinal cord injury (SCI). At about 1 year after injury, in most cSCI subjects the neuronal dysfunction is fully established and remains more or less stable in the following years. It is assumed that in chronic SCI, the patient's immobility resulting in a reduced input from supraspinal and peripheral sources leads to a predominance of inhibitory drive within spinal neuronal circuitries underlying locomotor pattern and SR generation. Training of spinal interneuronal circuits including the enhancement of an appropriate afferent input might serve as an intervention to prevent neuronal dysfunction after an SCI.

Entities:  

Mesh:

Year:  2010        PMID: 21060314     DOI: 10.1038/sc.2010.147

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  8 in total

1.  Neuromuscular training based on whole body vibration in children with spina bifida: a retrospective analysis of a new physiotherapy treatment program.

Authors:  C Stark; H-K Hoyer-Kuhn; O Semler; L Hoebing; I Duran; R Cremer; E Schoenau
Journal:  Childs Nerv Syst       Date:  2014-11-05       Impact factor: 1.475

2.  Stepping responses to treadmill perturbations vary with severity of motor deficits in human SCI.

Authors:  Virginia W T Chu; T George Hornby; Brian D Schmit
Journal:  J Neurophysiol       Date:  2018-04-18       Impact factor: 2.714

3.  Motor axonal regeneration after partial and complete spinal cord transection.

Authors:  Paul Lu; Armin Blesch; Lori Graham; Yaozhi Wang; Ramsey Samara; Karla Banos; Verena Haringer; Leif Havton; Nina Weishaupt; David Bennett; Karim Fouad; Mark H Tuszynski
Journal:  J Neurosci       Date:  2012-06-13       Impact factor: 6.167

4.  Molecular Mechanisms Underlying Cell Death in Spinal Networks in Relation to Locomotor Activity After Acute Injury in vitro.

Authors:  Anujaianthi Kuzhandaivel; Andrea Nistri; Graciela L Mazzone; Miranda Mladinic
Journal:  Front Cell Neurosci       Date:  2011-06-17       Impact factor: 5.505

Review 5.  Multimodal treatment for spinal cord injury: a sword of neuroregeneration upon neuromodulation.

Authors:  Ya Zheng; Ye-Ran Mao; Ti-Fei Yuan; Dong-Sheng Xu; Li-Ming Cheng
Journal:  Neural Regen Res       Date:  2020-08       Impact factor: 5.135

Review 6.  The physiological basis of neurorehabilitation--locomotor training after spinal cord injury.

Authors:  Michèle Hubli; Volker Dietz
Journal:  J Neuroeng Rehabil       Date:  2013-01-21       Impact factor: 4.262

7.  Antibody-mediated inhibition of Nogo-A signaling promotes neurite growth in PC-12 cells.

Authors:  Iman K Yazdi; Nima Taghipour; Sarah Hmaidan; Roberto Palomba; Shilpa Scaria; Alvaro Munoz; Timothy B Boone; Ennio Tasciotti
Journal:  J Tissue Eng       Date:  2016-01-28       Impact factor: 7.813

Review 8.  Toward a Better Regeneration through Implant-Mediated Immunomodulation: Harnessing the Immune Responses.

Authors:  Ben Zhang; Yingchao Su; Juncen Zhou; Yufeng Zheng; Donghui Zhu
Journal:  Adv Sci (Weinh)       Date:  2021-06-12       Impact factor: 16.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.